One exciting area that has emerged through genetic analysis of the lactococci is the definition and practical application of gene systems that provide phage resistance to these industrially important bacteria. Naturally occurring phage-insensitive strains have been characterized and found to harbour multiple defence systems which can act at different points of the lytic cycle to prevent the successful adsorption, infection, or replication of virulent phages [ 11.
Although phage attack on lactococcal starter cultures is still a major problem for the cultured dairy products industries, this can now be successfully addressed using genetic approaches to construct strains which are resistant to the phages often encountered in the industry [2, 31. In this paper I will describe the various phage defence systems that are naturally present in lactococci, their individual and combined effects, and the genetic strategies which are currently available to construct phageinsensitive strains for dairy fermentations. In addition, I will discuss the molecular responses of virulent phages which have appeared in the industry following the introduction and use of specialized starter cultures carrying defined mechanisms of phage resistance. The genetic routes whereby industrial phages elicit counter-defences against lactococcal resistance mechanisms provide new and important information that will facilitate the development of improved starter culture systems and phage-resistant lactic acid bacteria.
Historically, starter strains that perform well in dairy fermentations have been selected on the basis of long-lived and consistent fermentative activity in phage-contaminated environments. Genetic analysis of Lactococcus lactis subsp. lactis and subsp. eremot6 strains over the past ten years has revealed that the lactococci harbour a variety of natural phage-defence systems. These include plasmid-encoded defences that interfere with phage adsorption, numerous DNA restriction and modification systems of different specificity, and undefined mechanisms that abort the phage infection after injection of phage DNA into the cell (for reviews see [4-61). Numerous phage-resistance plasmids encoding the above classes of resistance Abbreviations used: IS, insertion sequence; LlaI and FokI, type 11-A-methy lase genes, mechanisms have now been detected and characterized in lactococci [7-261. The common association with plasmid DNA, and often conjugative elements, explains the wide distribution of phageresistance mechanisms among different strains. Noting the role of plasmid DNA in bacterial evolution, this further indicates that these are critical genotypes that have contributed to the survival and adaptation of lactococci in milk-based environments [2, 27, 281. Combinations of resistance mechanisms which act at different points of the phage lytic cycle provide a higher order of protection to strains that appear to be 'insensitive' to phage attack [ 11. Such phage-insensitive strains have been naturally selected and then perpetuated in the industry on the basis of their consistent and reliable performance in cultured dairy product fermentations that are routinely contaminated by phage. As a consequence, these prototype strains not only provide a genetic source of defence systems that could be employed in the construction of improved strains, but also illustrate how natural selection has effectively combined different resistance mechanisms to achieve a phage-insensitive condition.
Genotypes and phenotypes of the phage resistance plasmid, PTR2030
The self-transmissible, phage resistance plasmid pTR2030 is present as a large-molecular-mass multimer in the prototype phage-insensitive strain Lactococcus lactis ME2 [l, 29, 301 where it is one component of the multiple phage defences harboured by this strain [ 11. Of the phage resistance plasmids characterized thus far, pTR2030 has at this juncture received the most thorough investigation of its genetic organization, mechanisms of phage resistance, conjugative ability, and practical utility. Therefore, the properties of this naturallyoccurring plasmid and its phage-defence systems will be presented to illustrate the components upon which unique phage-resistant lactic acid bacteria could be designed.
Plasmid pTR2030 was first discovered in lactose-fermenting (Lac+), phage-resistant transconjugants formed by matings with the prototype phage-insensitive strain, L. lactis M E 2 The plasmid is a 46.2 kb self-transmissible conjugal element which encodes the following phage-resistance phenotypes: Hsp+ , an abortive infection mechanism described initially as a heat-sensitive reduction in the burst size and efficiency of plaquing (EOP) of the prolate-headed phage C2 [30] 331 . In a majority of lactococcal strains, pTR2030 provides complete resistance to the most common species of disruptive phage found in the dairy industry, small isometric phages. In the strain backgrounds examined to date, prolate phages are also inhibited, but to a lesser degree [30, 331. Prolate phages will typically plaque at efficiencies of 0.1 to 0.001 and form small plaques owing to a reduction in the burst size of progeny phage. Although prolate phages are highly virulent and exhibit a wide host range among select lactococcal strains, they appear to be less problematic in those strains that are more commonly used in cheese making. Nevertheless, prolate phages remain a significant disruptive species for which effective defences have been discovered on other lactococcal conjugative plasmids [7-9, 15, 191 . For pTR2030, it is now evident that the bacterial host background, phage species, and the infecting phage strain will effect the resistance phenotype observed. With this level of phenotypic heterogeneity, it is imperative that the phages and defence mechanisms be characterized in depth so as to establish the relative contributions of each to the resistance phenotype detected.
Molecular characterization of pTR2030 has localized the region responsible for the Hsp and R/M activities [31, 341 and defined two copies of an insertion sequence, IS946, an 808 bp element that shares 96% identity with ISSZ [35, 361. 20, 36, 371 , and it has now been demonstrated that they are likely to contribute to inter-and intramolecular recombination events that result in the movement, loss, and rearrangement of phage-resistance genes and gene systems [20, 36, 371 .
The essential region for hsp was defined by T n 5 mutagenesis, cloned, and sequenced [34] . A 3 kb region was completely sequenced and a structural gene of 1887 bp identified which could encode a protein with a predicted molecular mass of 73.8 kDa [38] . Expression signals upstream of hsp direct the constitutive expression of cat86 on pGKV210 [39] , suggesting that the transcription of hsp is not induced in response to phage infection. The specific role of the hsp protein in conferring phage resistance to lactococci remains to be elucidated. However, using a rapid method to evaluate intracellular phage DNA replication, we have obtained evidence suggesting that the action of Hsp occurs at the level of phage DNA replication [40] following injection of phage DNA into the cell [6, 30, 411 . Interference with phage DNA replication would be expected to stop lytic development completely or severely limit the number of progeny phage that burst from Hsp+-infected cells. This type of response has been reported for both prolateand small isometric-headed phages in lactococci harbouring Abi/Hsp plasmids [7, 13, 15, 20, 21, 30, 411. The specific mechanism through which the product of the hsp gene interferes with phage DNA replication or prevents the use or redistribution of the host's replicative machinery is not yet known. In this light, it is interesting that at least two genotypes representing abortive mechanisms exist in lactococci [21, 381 . Perhaps numerous targets exist for the action of abortive-type mechanisms or, as is the case with many classes of proteins and enzymes, the gene products are structurally heterogeneous but maintain some common functional domain which acts to interfere with the phage DNA cycle in a similar manner.
The location of the RIM determinants on pTR203O was defined after the 14.6 kR BglII fragment was cloned into the Escherichia coli-Lactococcus shuttle vector pSA3 to form pTK6 ( Fig. 1 ; [34] LlaI [42] . The LlaI gene is 1866 bp in length and encodes a protein of 622 amino acids with predicted molecular mass of 72.5 kDa. Two consensus sequences which are found in all type 11-A-methylases were each found twice within the LlaI gene (Fig. 2) . The first consensus sequence, found in all type I1 methylases [43] , is located at the 'amino' terminus of each methylase domain in LlaI. Two DPPY consensus sequences, located in the carboxyl domain of only type 11-A-methylases [43] , were also present in LlaI. This organization is strikingly similar to an atypical type 11-A-methylase, FokI, in that two methylase domains are organized in tandem [44] . Similarly to FolzI, LlaI contains two functional methylase domains which may recognize non-palindromic sequences by acting as an asymmetric dimer to modify the complementary sequences on opposite strands. The available data indicate that pTR2030 encodes a type 11-A-methylase with potentially two functional methylase domains. The restriction gene(s) have yet to be localized and characterized. Together these mechanisms create a powerful barrier to phage infection and proliferation, and thereby also minimize the potential for phage adaptation through mutation, recombination, or hostdependent modification.
Combined effects of WM and abortive infection defences

Genetic strategies for the construction of phage-insensitive strains
In addition to the RIM and Abi defences carried by pTR2030, this plasmid is self-transmissible and can direct its own conjugative transfer into other lactococcal strains [30, The use of genetic 'addition' strategies has allowed us to improve upon the phage resistance of lactococcal starter strains which are currently available, while minimizing secondary effects that could have a negative impact on their industrial performance. This strategy is now widely applicable for the construction of phage-resistant lactococci given, the availability of a number of different, naturallyoccurring phage-resistance plasmids that have been defined, and noting the improvement in gene transfer methodologies via conjugation and electroporation. It is not yet clear, however, whether or not electroporation will be considered a food-safe genetic technology that can be used in the construction of improved lactococcal strains. This would be unfortunate, because it is a benign process that is generally applicable for delivery of DNA to bacteria which are recalcitrant to other genetic transfer systems.
Phage counter-defences
Phage-resistant transconjugants bearing pTR2030 have been used successfully in the dairy industry since 1985. Over this period, a number of phages have been isolated from industrial sources where the transconjugants were being manufactured or used. One small isometric-headed phage, designated nck202.$50, was not inhibited by the R/M or Hsp-abortive mechanisms encoded by pTR2030. This phage was characterized at the molecular level to elucidate the genetic routes whereby lactococcal phages can evolve counter-defences to defence mechanisms engineered into dairy starter cultures [32] . Phage $50 is a double-stranded DNA phage with a genome of 29.8 kb. Its genone is circularly permuted, with a terminal redundancy of 2.2 kb and a puc site. Initial characterization revealed that phage $50 showed a region of homology to the RIM region defined on pTR2030 [32] . Molecular analysis and DNA sequencing of $50 and pTR2030 revealed that the phage genome contained 1273bp of the pTR2030-LlaI DNA sequence which corresponded to the amino domain of the type II-Amethylase [42] . The phage also contained the LlaI expression signals upstream from the first 344 codons of the methylase gene (Fig. 2) . The amino domain of LlaI provides a functional modification activity [42] and, therefore, phage $50 is capable of self-methylation in any propagating host. Consequently, $50 is not susceptible to restriction by the LlaI system encoded by pTR2030. However, it is important to point out that this is not an especially virulent phage, since 4.50 continues to be sensitive to restriction by other lactococcal R/M systems of different specificity from LlaI [32] . There 
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Type Il-A-methylase -C-terminus Volume 19 tion of restriction sites in the phage genome, incorporation of unusual bases, and DNA modifications other than methylation (i.e. glucosylation by phage T4). T o our knowledge the acquisition and expression of a functional region of a bacterial methylase gene is unique among the phage counter-defences described previously. The pTR2030-encoded abortive system inhibits DNA replication of phages post-injection by an unknown mechanism [40, 411. Phage $50, however, does not suffer an aborted infection on pTR2030 transconjugants and replication of its genome is not retarded. One region of DNA homology was identified between the phage $50 genome and a second phage ($48) which was also resistant to the abortive action of pTR2030 [32] . This region in phage $50 was cloned, sequenced, and characterized as a phage origin of replication [49] . These data suggest that the phage origin of replication may be a critical target for the action of abortive-type mechanisms. Moreover, bacteriophages exist or can evolve changes in their replication origin so that they are unaffected by this abortive defence. It remains to be established whether or not the abortive mechanisms of phage resistance encoded by pTR2030 can act on different phage origins of replication or at different points of the phage lytic cycle, or both.
Development of starter systems
Historically, starter strains that perform well in dairy fermentations have been selected on the basis of long-lived and consistent fermentative activity in phage-contaminated environments. In recent years, the continuous use of 5 to 6 strains in a multiplestrain starter culture system has been widely advocated and employed in the cultured dairy products industries [SO] . Phage-unrelated strains are selected on the basis of their fermentative characteristics, relative phage resistance, and compatibility with other strains incorporated into the multiple-strain starter. When phage are detected against any one strain in the composite culture, that strain is removed and replaced with a new phage-unrelated strain, or a phage-resistant derivative. In the majority of instances, the replacement strain is a host-range derivative of the phage-sensitive parent which either does not adsorb phage particles or does not support proliferation of the disturbing phage. In either case, overall protection of the starter system is based on the premise that phage will be diluted out of the environment, since a replicating host is not maintained in the multiple-strain culture. The success of this system is based on a routine screening for phage populations, early detection of new virulent phages, and the availability of suitable replacement strains that are truly phage unrelated.
With the anticipated improvements in lactococci resulting from directed genetic manipulations, the industry will become more and more reliant on highly specialized strains. The longevity and usefulness of such strains will be dictated by their phage resistance or sensitivity. Therefore, in the future we must begin to design starter culture systems that can protect one or two highly specialized strains which are intended for continuous and long-term industrial use. We have recently devised a novel culture rotation system which employs derivatives of a single strain which are genetically modified so as to contain different phage-defence mechanisms [S 11. The types, combinations, and specificity of different resistance mechanisms are varied in isogenic derivatives of one bacterial host strain. The different derivatives are then used in either mixed cultures or in a designed sequence that rotates the isogenic variants containing different defence systems. Alternating phage defences in a set of isogenic derivatives is intended to protect each strain against phage infection as well as minimize the potential for adaptation of new phage that are insensitive to any single set of defence systems. The 'phage-defence rotation strategy' provides an attractive and simple approach to protecting the long-term usefulness of specialized strains that carry multiple phage-resistance mechanisms. Details of this strategy will be published elsewhere [ S 1 1.
Conclusions
Molecular characterization of pTR2030 has revealed two defence systems that co-operate to prevent phage infection and proliferation. Combinations of such naturally-occurring phage defences are commonly found in lactococci and most likely reflect the adaptation of these bacteria to a phagecontaminated environment which must be highly selective for sophisticated defence systems. As replicons and genes encoding phage defences have been characterized to the molecular level over the past decade, it has become clear that phage resistance in lactococci is both fundamentally important and industrially significant. The lactococci may well represent the most dynamic bacterial species in which to investigate phage-host interactions and study cycles of bacterial defence and phage counter-defence. This information has already facilitated the design of new strains and starter culture systems that are less susceptible to attack by 679 bacteriophage. Looking ahead, more emphasis should now be focused on the expression and regulation of genes encoding phage resistance and the co-operativity between phage-defence systems. Expression of these gene systems in heterologous hosts still awaits exploration, but this work should have a dramatic impact on the effectiveness and industrial longevity of numerous types of starter cultures and strains of lactic acid bacteria that suffer from attack by bacteriophages. proteolysis which could produce off-flavoured peptides. Availability of this enzyme is subject to fluctuations in the veal market, and consequently, it is both expensive and frequently in short supply. For these reasons expression of bovine chymosin in micro-organisms has been a goal of several biotechnology companies, and to date researchers have expressed bovine chymosin cDNA sequences in bacteria [15] . Three of the plasmid constructions involved coupling of prochymosin cDNA to glaA sequences at either the glucoamylase signal peptide cleavage site (pGKG l), the glucoamylase propeptide cleavage site (pCRG2), or after 11 codons of the mature glucoamylase (pCRG4). A fourth construction involved joining preprochymosin sequences directly to the glaA promoter (pCRG3).
The development of
Transformants generated with each of the four expression vectors secreted active chymosin into the culture medium when they were grown in medium which contained starch or maltose as sole carbon sources to induce the glaA promoter (Table  1) . Extremely low amounts of chymosin were produced in cultures which used xylose as the carbon source. Collectively, these two observations suggest that the heterologous A. nigerglaA promoter is also starch-or maltose-inducible in A. niduluns. Extracellular chymosin levels varied widely among transformants derived from a single vector. Surprisingly, there was no strict correlation between chymosin i 8 I
